|
|
|
Volumn 1, Issue 30, 2005, Pages 1931-1932
|
|
From therapeutic surplus to surcharge of a new medicine: Report of an increasing hiatus;De la plus-value thérapeutique au surcoût d'un nouveau médicament: À propos d'un hiatus croissant
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CYCLOOXYGENASE 2 INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PLACEBO;
DRUG;
ATHEROSCLEROSIS;
EDITORIAL;
MEDICAL LITERATURE;
MEDICAL PERSONNEL;
REMISSION;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMICS;
HEALTH CARE DELIVERY;
HUMAN;
CLINICAL TRIALS;
DELIVERY OF HEALTH CARE;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
|
|
EID: 27744461310
PISSN: 16609379
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
